AAPL 188.99 -0.13 (-0.07%)MSFT 128.09 -0.03 (-0.02%)FB 185.32 +0.01 (+0.01%)ZNGA 6.19 -0.01 (-0.16%)NVDA 156.55 +0.3 (+0.19%)WBA 52.27 -0.05 (-0.09%)GOOG 1161.8 -0.53 (-0.05%)PIH 5.82 +0.25 (+4.49%)
AAPL 188.99 -0.13 (-0.07%)MSFT 128.09 -0.03 (-0.02%)FB 185.32 +0.01 (+0.01%)ZNGA 6.19 -0.01 (-0.16%)NVDA 156.55 +0.3 (+0.19%)WBA 52.27 -0.05 (-0.09%)GOOG 1161.8 -0.53 (-0.05%)PIH 5.82 +0.25 (+4.49%)

Financial Statements KALV Quote KalVista Ph

All | Income Statement | Balance Sheet | Cash Flow | Retained Earnings | PPE Schedule | Intangible and Goodwill Schedule
Income Statement
Year 20142015201620172018
Revenue 2 0 2 0 0
COGS 0 0 0 0 0
GrossProfit 2 0 2 2 8
Depreciation (included in COGS) 0 0 0 0 0
StockBasedCompe (included in COGS) 0 1 0 0 1
ResearchAndDeve 8 16 15 13 18
SalesGeneralAnd 2 5 3 11 9
OperatingIncome -8 -21 -15 -22 -19
InterestExpense 0 1 0 0 0
OtherIncome 1 -3 4 4 3
IncomeBeforeTax -7 -25 -11 -19 -16
ProvisionForInc 0 0 0 0 0
NetIncome -7 -25 -11 -19 -16
Balance Sheet
Year 20142015201620172018
CashAndCashEqui 4 54 22 31 51
ShortTermInvest 0 0 0 0 0
Cash 4 54 22 0 0
AccountReceivab 0 0 2 0 0
Inventories 0 0 0 0 0
DeferredIncomeT 0 0 0 0 0
OtherCurrentAss 0 0 0 0 0
TotalCurrentAss 5 55 25 34 59
PPE 1 1 0 0 2
AccumulatedDepr 0 -1 0 0 -1
NetPPE 0 1 0 0 2
EquityAndOtherI 0 0 0 0 0
Goodwill 0 0 0 0 0
IntangibleAsset 0 0 0 0 0
OtherLTAssets 2 1 0 0 0
TotalNonCurrent 2 2 0 0 2
TotalAssets 7 57 25 34 61
ShortTermDebt 4 1 0 0 0
AccountsPayable 1 1 1 0 0
TaxesPayable 0 0 0 0 0
AccruedLiabilit 2 1 1 0 0
DeferredRevenue 0 0 0 0 18
OtherCurrentLia 0 0 1 1 1
TotalCurrentLia 7 4 3 3 23
Debt 2 3 0 0 0
DeferredTaxesLi 0 0 0 0 0
DeferredRevenue 0 0 0 0 0
OtherLTLiabilit 42 0 59 0 11
TotalNonCurrent 44 3 59 0 11
TotalLiabilitie 51 7 62 3 34
CommonStock 0 0 0 0 0
AdditionalPaidI 4 122 0 90 100
RetainedEarning -48 -73 -37 -56 -72
AccumulatedOthe 0 0 0 -3 -1
TotalStockholde -44 49 -37 31 27
TotalLiabilitie 7 57 25 34 61
Cash Flow Statement
Year 20142015201620172018
NetIncome -7 -25 -11 -19 -16
Depreciation 0 0 0 0 0
DeferredIncomeT 0 0 0 0 0
StockBasedCompe 0 1 0 0 1
AccountsReceiva 0 0 0 0 0
InventoryCS 0 0 0 0 0
AccountsPayable 0 0 0 -2 0
OtherWorkingCap 0 0 -1 -1 25
OtherNonCashIte 0 4 -2 -1 -1
NetCashProvided -6 -21 -13 -24 11
InvestmentsInPP 0 -1 0 0 -1
AcquisitionsNet 0 0 0 0 0
PurchasesOfInve 0 0 0 0 0
SalesMaturities 0 0 0 0 0
PurchasesOfInta 0 0 0 0 0
OtherInvestingA 0 0 0 34 0
NetCashUsedForI 0 -1 0 34 -1
DebtIssued 0 4 0 0 0
DebtRepayment 0 0 0 0 0
CommonStockIssu 0 68 0 0 9
CommonStockRepu 0 0 0 0 0
DividendPaid 0 0 0 0 0
OtherFinancingA 0 0 0 0 0
NetCashProvided 9 72 33 0 9
NetChangeInCash 2 50 19 9 20
CashAtBeginning 0 4 3 22 31
CashAtEndOfPeri 3 54 22 31 51
Retained Earnings
Year 20142015201620172018
RetainedEarning ----48-73
NetIncome ---7-25-11
StockDividend --5550-25
DividendPaid -----
RetainedEarning ---48-73-37
Property Plant and Equipment Schedule
Year 20142015201620172018
NetPPE ----1
DeprAnnual 0---11
CapitalExpendit 00010
NetPPE ---1-
Intangible and Goodwill Schedule
Year 20142015201620172018
intAndGW 0----
Amortization 0--1-1
NewPurchases 0---11
intAndGW -----
KalVista Pharmaceuticals Inc. income statement is the only one that provides an overview of company sales and net income
The reasoning behind the adjustment, however, is that free cash flow is meant to measure money being spent right now, not transactions that happened in the past. This makes KalVista Pharmaceuticals Inc. FCF a useful instrument for identifying growing companies with high up-front costs, which may eat into earnings now but have the potential to pay off later.